Table 1.
Summary of study population.
Table 2.
Overall performance characteristics of the InBios and Bio-Rad assays compared to reference standarda.
Table 3.
Sensitivity of InBios and Bio-Rad assays differentiated by primary or secondary infection.
Figure 1.
Sensitivity of InBios and Bio-Rad Assays stratified by date after onset of illness in (A) All infections and in (B) Primary and (C) Secondary infections.
Serum samples (total samples, n = 314; primary, n = 51; secondary, n = 260) were tested using the InBios and Bio-Rad NS1 kits. Sensitivity was plotted against day post-onset of illness. p-values were calculated using McNemar's Chi-square test. NA – not applicable. Unable to do statistical analysis when value equals 0. NS – not significant.
Table 4.
Sensitivity of InBios and Bio-Rad assays based on serotype.
Table 5.
Sensitivity of InBios and Bio-Rad assays based on clinical diagnosis and serological diagnosis.